Company Overview Press Releases Events Careers Login
Raysun Biopharma
Raysun cleanroom team reviewing sterile manufacturing operations

Development Services

Services OverviewIntegrated pathways for peptide APIs and sterile drug-product development Peptide API DevelopmentProgram planning from API strategy through analytical and process development Sterile FDF DevelopmentFormulation, presentation selection and technology-transfer planning Project InquiryDiscuss technical requirements, development scope and next steps

Manufacturing & Facility

Manufacturing OverviewMulti-product sterile platform under development in Laos Facility DevelopmentCurrent construction, cleanroom and equipment-integration status SustainabilityResponsible design, utilities and safe systems of work Project UpdatesVerified construction and company progress

Sterile Dosage Forms

Dosage Forms OverviewFlexible product-development presentations Single-Chamber CartridgesCartridge filling and assembly pathways Dual-Chamber CartridgesTwo-component cartridge system development Lyophilized VialsVial filling, freeze-drying and capping pathways
Lyophilized Vials
Review lyophilized vial development inputs and ten Tirzepatide configurations for qualified B2B project evaluation with Raysun.

Tirzepatide Lyophilized Vial
5 mg nominal total content | 3 mL vial | Concept
Tirzepatide Lyophilized Vial
10 mg nominal total content | 3 mL vial | Concept
Tirzepatide Lyophilized Vial
15 mg nominal total content | 3 mL vial | Concept
Tirzepatide Lyophilized Vial
30 mg nominal total content | 6 mL vial | Concept
Tirzepatide Lyophilized Vial
40 mg nominal total content | 6 mL vial | Concept
Tirzepatide Lyophilized Vial
50 mg nominal total content | 6 mL vial | Concept
Tirzepatide Lyophilized Vial
60 mg nominal total content | 6 mL vial | Concept
Tirzepatide Lyophilized Vial
100 mg nominal total content | 10 mL vial | Concept
Tirzepatide Lyophilized Vial
120 mg nominal total content | 10 mL vial | Concept
WhatsAppWhatsApp QR